Literature DB >> 15627203

Epsilon-sarcoglycan is not involved in sporadic Gilles de la Tourette syndrome.

Friedrich Asmus, Sarah Schoenian, Peter Lichtner, Marita Munz, Petra Mayer, Bertram Muller-Myhsok, Alexander Zimprich, Helmut Remschmidt, Johannes Hebebrand, Oliver Bandmann, Thomas Gasser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15627203     DOI： 10.1007/s10048-004-0206-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN： 1364-6745            Impact factor:   2.660


× No keyword cloud information.
  6 in total

1.  A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission.

Authors:  D Clayton
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

2.  Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3.

Authors:  L Boghosian-Sell; D E Comings; J Overhauser
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 3.  Tics.

Authors:  Tamara Pringsheim; William Jeptha Davenport; Anthony Lang
Journal:  Curr Opin Neurol       Date:  2003-08       Impact factor: 5.710

4.  Lack of mutations in the epsilon-sarcoglycan gene in patients with different subtypes of primary dystonias.

Authors:  Kathrin Grundmann; Ulrike Laubis-Herrmann; Dirk Dressler; Juliane Vollmer-Haase; Peter Bauer; Manfred Stuhrmann; Thorsten Schulte; Ludger Schöls; Helge Topka; Olaf Riess
Journal:  Mov Disord       Date:  2004-11       Impact factor: 10.338

5.  Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype.

Authors:  Friedrich Asmus; Alexander Zimprich; Sophie Tezenas Du Montcel; Christian Kabus; Günther Deuschl; Andreas Kupsch; Ulf Ziemann; Mirna Castro; Andrea A Kühn; Tim M Strom; Marie Vidailhet; Kailash P Bhatia; Alexandra Dürr; Nicholas W Wood; Alexis Brice; Thomas Gasser
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

6.  Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder.

Authors:  Patricia de Carvalho Aguiar; Melissa Fazzari; Joseph Jankovic; Laurie J Ozelius
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.